RWA WEALTH PARTNERS, LLC

Position in BHVN — Biohaven Ltd.

CIK 1544576 BOSTON, MA

Position in BHVN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$342,240

-$18,330 QoQ

Shares Held

23,000

-4.3% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#160

of 291 holders

Holding Since

Jun 2024

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

RWA WEALTH PARTNERS, LLC holds $2,823,823 across 5 Biotechnology names. BHVN ranks #4 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,714	$1,348,124
2	EXEL	Exelixis, Inc.	8,806	$479,134
3	CRNX	Crinetics Pharmaceuticals, Inc.	9,271	$346,920
4	BHVN	Biohaven Ltd. This page	23,000	$342,240
5	REGN	Regeneron Pharmaceuticals, Inc.	493	$307,405

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$342,240	23,000	-4.3%	Shares	Sole	2026-08-07
2025-09-30	$360,570	24,022	+90.3%	Shares	Sole	2025-11-10
2025-03-31	$303,432	12,622	+7.0%	Shares	Sole	2025-05-13
2024-12-31	$440,730	11,800	+81.5%	Shares	Sole	2025-02-12
2024-09-30	$324,805	6,500	0.0%	Shares	Sole	2024-11-08
2024-06-30	$225,615	6,500	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.